José Valdez Madruga
José Valdez Madruga is a principal investigator at the Casa da Pesquisa do Centro de Referência em Treinamento para DST/AIDS in São Paulo, specializing in HIV and STIs, who has participated in clinical studies on lenacapavir and advocates for its effectiveness as a long-acting treatment option for individuals living with HIV.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Brazil | 2 | 9.00 | 0.18% | +0% | 211,049,527 | 375,199 | $1,500,000 | 2,667$ |
| Totals | 2 | 211,049,527 | 375,199 | $1,500,000 | 2,667$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Brazil:
José Valdez Madruga is the principal investigator of clinical studies at the Research House of the Reference Center for Training in STD/AIDS in São Paulo and has had an excellent experience with lenacapavir in clinical trials.
9
Brazil:
José Valdez Madruga is the principal investigator of clinical studies at the Research House of the Reference Center for Training in STD/AIDS in São Paulo and has had an excellent experience with lenacapavir in clinical trials.
9